OrganOx Completes $142m Equity Financing Round
Deal News | Feb 24, 2025 | Business Growth Fund (BGF)
OrganOx, a leader in organ technology, has successfully closed a $142 million equity financing round. This significant funding is part of the investments from the Business Growth Fund (BGF), which has included OrganOx in its Early Stage investment portfolio. The capital injection is set to enhance OrganOx's position as a frontrunner in the organ tech industry, enabling further advancements and solidifying its market leadership.
Sectors
- Healthcare Technology
- Private Equity and Venture Capital
Geography
- United Kingdom – The Business Growth Fund (BGF) is based in the UK and is a key participant in the financing round for OrganOx.
Industry
- Healthcare Technology – The article is about OrganOx, a company involved in developing technology for organ preservation and transplantation.
- Private Equity and Venture Capital – The involvement of the Business Growth Fund (BGF) as an investor in OrganOx's equity financing identifies this article within the realm of private equity and venture capital.
Financials
- $142 million – The amount raised by OrganOx in its equity financing round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| OrganOx | Target company | Company | A leading company in organ technology focused on organ preservation and transplantation. |
| Business Growth Fund (BGF) | Investor | Company | A UK-based private equity firm focusing on early-stage investments. |